Corporate Social Responsibility | Business Wire | PR NewsWire | Marketwire | Realwire | ACN/JCN newswire | 247pressrelease | PRWeb

OssulinTM, a Novel Oral Insulin Product, Shows Promising Bioavailability for Advancing Diabetes Therapy

Posted : Mon, 09 Nov 2009 10:00:37 GMT
Author : CM&D Pharma Limited
Category : Press Release
News Alerts by Email ( click here )
News | Home
LONDON - (Business Wire) New data from Puredel Limited, presented at the 9th Annual Diabetes Technology Meeting in San Francisco, CA, suggests that higher blood levels of insulin were achieved by Ossulin™ than had been previously demonstrated by other oral products. In a series of experiments covering a range of doses and models, Ossulin™ consistently delivered around 20% of the insulin dose into the bloodstream.

The authors concluded that:

"Ossulin provides an efficient way to deliver insulin to the body via oral administration, resulting in blood levels higher than those previously observed with other oral insulin products."

Lead author and Chief Scientific Officer for Puredel, Dr. Marco Prosdocimi added:

"Oral insulin could represent a major advance in diabetes therapy through its simplicity of use, and because it mimics the natural physiological route of the hormone. The incorporation of insulin into the proprietary delivery agent NatsomTM gives rise to a product which is not destroyed by the gastric environment."

About Puredel Limited

Puredel is focusing its research on the development of Ossulin™, which has shown promising results in preliminary studies. Puredel will also explore other target molecules which are currently injected, and whose oral administration would greatly improve patient convenience and compliance. Natreon’s R&D staff and facilities in the United States and India are working closely with Puredel to help facilitate the next stage of scientific validation prior to commercial development.

Puredel will coordinate the product development of Ossulin™ up to proof of clinical efficacy, drawing on its extensive network of scientific experts in Europe and North America.

For further information and a copy of the abstract, please contact:
Stephen Appelbee, CEO, CM&D Pharma Limited
+44 20 7259 8488

appelbee@cmdpharmaltd.com

www.cmdpharmaltd.com

CM&D Pharma Limited
Stephen Appelbee, CEO, +44 20 7259 8488
appelbee@cmdpharmaltd.com
www.cmdpharmaltd.com


Copyright © 2008 Business Wire. All rights reserved.
Share/Save/Bookmark

Article : OssulinTM, a Novel Oral Insulin Product, Shows Promising Bioavailability for Advancing Diabetes Therapy
Print this article
Share this article

Stay Updated

News gadget on your Google homepage
Subscribe to a news feed in Google Reader



Related News

Power Tagging Announces National Science Foundation Grant
Company Selected Amongst Thousands to Continue to Evolve Data Structures to Support the Emerging NIST Smart Grid Standards./I/P P(PRWEB) November 22, 2009 -- Power Tagging, a leading provider of next generation smart grid communications technologies, today announced that the company has...

2011 Cadillac CTS Coupe: New Sports Coupe Is Cadillac's Most Dramatic Design
LOS ANGELES, Nov. 23 /PRNewswire/ -- Cadillac today unveiled the 2011 CTS Coupe, the latest and most dramatic of the brand's series of new designs to reach production. Slated to arrive in Cadillac showrooms in the spring of 2010, the CTS Coupe is a new luxury sports coupe designed t...

U.S. Census Bureau Daily Feature for Nov. 23
WASHINGTON, Nov. 23 /PRNewswire-USNewswire/ -- Following is the daily "Profile America" feature from the U.S. Census Bureau: (Logo: http://www.newscom.com/cgi-bin/prnh/20090226/CENSUSLOGO)

Majorities Reject Banning Defamation of Religion: 20 Nation Poll
COLLEGE PARK, Md., Nov. 23 /PRNewswire-USNewswire/ -- As the UN General Assembly prepares to debate a proposal calling for nations to take action against the defamation of religion, majorities in 13 of 20 nations polled around the world support the right to criticize a religion.

Amid the Flu Epidemic, Don't Forget RSV in Young Children
RSV found to cause far more emergency department visits and hospitalizations than seasonal flu BOSTON, Nov. 23 /PRNewswire-USNewswire/ -- Influenza, particularly H1N1, has understandably captured the attention of public health officials, the media and the public...

Peter Wilkinson Appointed IPREX President Asia Pacific
ATLANTA - Peter Wilkinson, CEO of Wilkinson PR, a full service corporate affairs and public relations agency with offices in Sydney, Melbourne and Perth, has been appointed President Asia Pacific of IPREX, the global corporation of independent public relations and communication firms.

Report Finds Girls' Schools in Afghanistan Face Highest Risk of Violence; Suggests Steps for Preventing Attacks
- New study supports community-based approach to education in Afghanistan - ATLANTA, Nov. 23 /PRNewswire-USNewswire/ -- Today CARE, the World Bank and the Afghanistan government released "Knowledge on Fire: Attacks on Education in Afghanistan," a groun...

Have your Say
Name
Email
Subject
Your Comment

Enter Verification code
 
  

 
Follow The Earth Times
Subscribe to RSS Follow Earth Times on TwitterNews by email
Share/Save/Bookmark
 
 



 
Subscribe to free Earthtimes
News Alerts by Email Click here
For RSS Feeds Click here
or Create your own RSS

Add to Google Toolbar
Breaking News
Press Releases

 


The Earth Times
News Category

© 2009 www.earthtimes.org, The Earth Times, All Rights Reserved | Privacy Policy
Earth Times accept no responsibility or liability either directly or indirectly for views or opinions expressed in articles or comments.